2 completed. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow Papilledema: new trials by email Literature Review of Papilledema trials Research Report on Papilledema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ozurdex for Macular Edema Post Membrane Peeling Dexamethasone, dexamethasone - Epiretinal Membrane, Cellophane Maculopathy | Phase 2 / Phase 3 | Completed | Retina Specialists, PC | 35 | 2010-06-01 | 2015-05-13 |
| Idiopathic Intracranial Hypertension Treatment Trial Acetazolamide, Placebo, Formal weight loss counselling program - Idiopathic Intracranial Hypertension | Phase 2 / Phase 3 | Completed | St. Luke's-Roosevelt Hospital Center | 165 | 2010-01-01 | 2018-12-12 |
Diplopia (1) · Epiretinal Membrane (1) · Headache (1) · Macular Edema (1) · Obesity (1) · Pseudotumor Cerebri (1) · Tinnitus (1) · Vision Disorders (1)
Cranial Nerve Diseases (2) · Eye Diseases (2) · Nervous System Diseases (2) · Optic Nerve Diseases (2) · Body Weight (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Ear Diseases (1) · Hearing Disorders (1) · Intracranial Hypertension (1) · Macular Degeneration (1) · Neurologic Manifestations (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Otorhinolaryngologic Diseases (1)
Acetaminophen (1) · Acetazolamide (1) · Aspirin (1) · Calcium Dobesilate (1) · Codeine (1) · Dexamethasone (1) · Ibuprofen (1) · Naproxen (1) · butalbital (1)
Retina Specialists, PC (1) · St. Luke's-Roosevelt Hospital Center (1)
United States (2) · Canada (1)
John Khadem, MD (1) · Michael Wall, MD (1)
PMID 24756302, PMID 24756514, PMID 24781936, PMID 25370510, PMID 25370513, PMID 26024112, PMID 26335066, PMID 26618282, PMID 26778344, PMID 26934136, PMID 27694262, PMID 28130349, PMID 28492874
U10EY017281 (1), U10EY017387 (1)